Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and tolerability of AZD 1208 up to a
maximum tolerated dose (MTD) and define the dose(s) for further clinical evaluation when
given daily to patients with advanced solid malignancies including malignant lymphoma